TY - JOUR
T1 - Development of harmaline-induced tremor in a swine model
AU - Lee, Jihyun
AU - Kim, Inyong
AU - Lee, Jeyeon
AU - Knight, Emily
AU - Cheng, Lei
AU - Kang, Shinil
AU - Jang, Dong Pyo
AU - Chang, Su Youne
N1 - Funding Information:
This study was funded by the National Institutes of Health, National Institute of Neurological Disorders and Stroke (NS 88260).
Publisher Copyright:
© 2018 Lee et al.
PY - 2018
Y1 - 2018
N2 - Background: In the field of translational neuroscience research, it is critical to utilize a large animal model to test the feasibility, safety, and functionality of novel therapies. Here, we describe a protocol for the development of a large animal model of tremor. Methods: In a pig model, tremor was induced with harmaline and measured with wireless accelerometers attached to the limbs. Three different doses of harmaline were tested and three repetitive injections were made at 72-hour intervals. To fully characterize the drug-induced tremor, onset time, tremor amplitude, maintained duration, and peak tremor frequency were analyzed. Results: Harmaline-induced tremor appeared immediately following intravenous injection of harmaline. Tremor was maintained over 2 hours. Its frequency was 10–16 Hz, which was independent of doses. Dose-dependent responses were observed in tremor amplitude, triggering time, and tremor-maintained duration. Repetitive injection of harmaline desensitized the harmaline effect. Discussion: We provide a detailed protocol for training, drug injection, device selection, and tremor recording optimized to create a swine model of tremor with harmaline. Our protocol provides reliable tremor in pigs and suggests pig as a valid translational large animal model of tremor.
AB - Background: In the field of translational neuroscience research, it is critical to utilize a large animal model to test the feasibility, safety, and functionality of novel therapies. Here, we describe a protocol for the development of a large animal model of tremor. Methods: In a pig model, tremor was induced with harmaline and measured with wireless accelerometers attached to the limbs. Three different doses of harmaline were tested and three repetitive injections were made at 72-hour intervals. To fully characterize the drug-induced tremor, onset time, tremor amplitude, maintained duration, and peak tremor frequency were analyzed. Results: Harmaline-induced tremor appeared immediately following intravenous injection of harmaline. Tremor was maintained over 2 hours. Its frequency was 10–16 Hz, which was independent of doses. Dose-dependent responses were observed in tremor amplitude, triggering time, and tremor-maintained duration. Repetitive injection of harmaline desensitized the harmaline effect. Discussion: We provide a detailed protocol for training, drug injection, device selection, and tremor recording optimized to create a swine model of tremor with harmaline. Our protocol provides reliable tremor in pigs and suggests pig as a valid translational large animal model of tremor.
KW - Animal model
KW - Harmaline
KW - Pig
KW - Tremor
KW - Wireless accelerometer
UR - http://www.scopus.com/inward/record.url?scp=85099288886&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099288886&partnerID=8YFLogxK
U2 - 10.5334/TOHM.406
DO - 10.5334/TOHM.406
M3 - Article
AN - SCOPUS:85099288886
SN - 2160-8288
VL - 8
SP - 1
EP - 6
JO - Tremor and Other Hyperkinetic Movements
JF - Tremor and Other Hyperkinetic Movements
M1 - 532
ER -